PHYTOMEDICINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向：中药单体 经验分享：请问换编辑后with editor assessment要多久才能under review，已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=2024-05-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=36, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2153099, encodeId=a8222153099ee, content=请问各位，第一次投稿的editor assessment大概多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Wed Aug 16 22:06:19 CST 2023, time=2023-08-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2205178, encodeId=ab7122051e892, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理学 经验分享：最近看了几篇文章：文章1: 收稿2024.1.20；修改2024.5.5；接受2024.5.15 文章2: 收稿2023.11.9；修改2024.3.12；接受2024.4.22 文章3: 收稿2023.6.29；修改2023.12.28；接受2024.5.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Fri May 17 13:28:46 CST 2024, time=2024-05-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了，😭😭😭，正常吗难道五一也放假了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193985, encodeId=ad53219398535, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15626507481, createdName=ms5000002039979243, createdTime=Tue Mar 19 06:01:55 CST 2024, time=2024-03-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京)]

2024-05-08 ms8000001555903844 来自北京

请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗

13 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向：中药单体 经验分享：请问换编辑后with editor assessment要多久才能under review，已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=2024-05-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=36, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2153099, encodeId=a8222153099ee, content=请问各位，第一次投稿的editor assessment大概多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Wed Aug 16 22:06:19 CST 2023, time=2023-08-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2205178, encodeId=ab7122051e892, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理学 经验分享：最近看了几篇文章：文章1: 收稿2024.1.20；修改2024.5.5；接受2024.5.15 文章2: 收稿2023.11.9；修改2024.3.12；接受2024.4.22 文章3: 收稿2023.6.29；修改2023.12.28；接受2024.5.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Fri May 17 13:28:46 CST 2024, time=2024-05-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了，😭😭😭，正常吗难道五一也放假了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193985, encodeId=ad53219398535, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15626507481, createdName=ms5000002039979243, createdTime=Tue Mar 19 06:01:55 CST 2024, time=2024-03-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京)]

2024-05-16 1225f99em69(暂无昵称) 来自江西省

偏重的研究方向：中药单体
经验分享：请问换编辑后with editor assessment要多久才能under review，已经十多天了😂

10 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向：中药单体 经验分享：请问换编辑后with editor assessment要多久才能under review，已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=2024-05-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=36, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2153099, encodeId=a8222153099ee, content=请问各位，第一次投稿的editor assessment大概多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Wed Aug 16 22:06:19 CST 2023, time=2023-08-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2205178, encodeId=ab7122051e892, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理学 经验分享：最近看了几篇文章：文章1: 收稿2024.1.20；修改2024.5.5；接受2024.5.15 文章2: 收稿2023.11.9；修改2024.3.12；接受2024.4.22 文章3: 收稿2023.6.29；修改2023.12.28；接受2024.5.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Fri May 17 13:28:46 CST 2024, time=2024-05-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了，😭😭😭，正常吗难道五一也放假了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193985, encodeId=ad53219398535, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15626507481, createdName=ms5000002039979243, createdTime=Tue Mar 19 06:01:55 CST 2024, time=2024-03-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京)]

2023-12-28 samtol 来自浙江省

让我修了两轮的格式和图片
12.25 submitted to journal
12.26 under editor assessment

44 36

展开36条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向：中药单体 经验分享：请问换编辑后with editor assessment要多久才能under review，已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=2024-05-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=36, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2153099, encodeId=a8222153099ee, content=请问各位，第一次投稿的editor assessment大概多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Wed Aug 16 22:06:19 CST 2023, time=2023-08-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2205178, encodeId=ab7122051e892, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理学 经验分享：最近看了几篇文章：文章1: 收稿2024.1.20；修改2024.5.5；接受2024.5.15 文章2: 收稿2023.11.9；修改2024.3.12；接受2024.4.22 文章3: 收稿2023.6.29；修改2023.12.28；接受2024.5.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Fri May 17 13:28:46 CST 2024, time=2024-05-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了，😭😭😭，正常吗难道五一也放假了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193985, encodeId=ad53219398535, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15626507481, createdName=ms5000002039979243, createdTime=Tue Mar 19 06:01:55 CST 2024, time=2024-03-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京)]

2024-05-07 ms8000001555903844 来自北京

大家submit to journal之后多久会变成with editor啊？

11 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向：中药单体 经验分享：请问换编辑后with editor assessment要多久才能under review，已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=2024-05-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=36, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2153099, encodeId=a8222153099ee, content=请问各位，第一次投稿的editor assessment大概多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Wed Aug 16 22:06:19 CST 2023, time=2023-08-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2205178, encodeId=ab7122051e892, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理学 经验分享：最近看了几篇文章：文章1: 收稿2024.1.20；修改2024.5.5；接受2024.5.15 文章2: 收稿2023.11.9；修改2024.3.12；接受2024.4.22 文章3: 收稿2023.6.29；修改2023.12.28；接受2024.5.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Fri May 17 13:28:46 CST 2024, time=2024-05-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了，😭😭😭，正常吗难道五一也放假了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193985, encodeId=ad53219398535, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15626507481, createdName=ms5000002039979243, createdTime=Tue Mar 19 06:01:55 CST 2024, time=2024-03-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京)]

2023-08-16 llllkn 来自浙江省

请问各位，第一次投稿的editor assessment大概多久呀？

38 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向：中药单体 经验分享：请问换编辑后with editor assessment要多久才能under review，已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=2024-05-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=36, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2153099, encodeId=a8222153099ee, content=请问各位，第一次投稿的editor assessment大概多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Wed Aug 16 22:06:19 CST 2023, time=2023-08-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2205178, encodeId=ab7122051e892, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理学 经验分享：最近看了几篇文章：文章1: 收稿2024.1.20；修改2024.5.5；接受2024.5.15 文章2: 收稿2023.11.9；修改2024.3.12；接受2024.4.22 文章3: 收稿2023.6.29；修改2023.12.28；接受2024.5.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Fri May 17 13:28:46 CST 2024, time=2024-05-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了，😭😭😭，正常吗难道五一也放假了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193985, encodeId=ad53219398535, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15626507481, createdName=ms5000002039979243, createdTime=Tue Mar 19 06:01:55 CST 2024, time=2024-03-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京)]

2024-05-17 suguoqing.my265 来自吉林省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：中药单体;药理学
经验分享：最近看了几篇文章：文章1: 收稿2024.1.20；修改2024.5.5；接受2024.5.15 文章2: 收稿2023.11.9；修改2024.3.12；接受2024.4.22 文章3: 收稿2023.6.29；修改2023.12.28；接受2024.5.7

11 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向：中药单体 经验分享：请问换编辑后with editor assessment要多久才能under review，已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=2024-05-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=36, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2153099, encodeId=a8222153099ee, content=请问各位，第一次投稿的editor assessment大概多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Wed Aug 16 22:06:19 CST 2023, time=2023-08-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2205178, encodeId=ab7122051e892, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理学 经验分享：最近看了几篇文章：文章1: 收稿2024.1.20；修改2024.5.5；接受2024.5.15 文章2: 收稿2023.11.9；修改2024.3.12；接受2024.4.22 文章3: 收稿2023.6.29；修改2023.12.28；接受2024.5.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Fri May 17 13:28:46 CST 2024, time=2024-05-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了，😭😭😭，正常吗难道五一也放假了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193985, encodeId=ad53219398535, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15626507481, createdName=ms5000002039979243, createdTime=Tue Mar 19 06:01:55 CST 2024, time=2024-03-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京)]

2024-05-02 1225f99em69(暂无昵称) 来自北京

状态一直停留在submitted to the journal 9天了，😭😭😭，正常吗难道五一也放假了？

16 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向：中药单体 经验分享：请问换编辑后with editor assessment要多久才能under review，已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=2024-05-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=36, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2153099, encodeId=a8222153099ee, content=请问各位，第一次投稿的editor assessment大概多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Wed Aug 16 22:06:19 CST 2023, time=2023-08-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2205178, encodeId=ab7122051e892, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理学 经验分享：最近看了几篇文章：文章1: 收稿2024.1.20；修改2024.5.5；接受2024.5.15 文章2: 收稿2023.11.9；修改2024.3.12；接受2024.4.22 文章3: 收稿2023.6.29；修改2023.12.28；接受2024.5.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Fri May 17 13:28:46 CST 2024, time=2024-05-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了，😭😭😭，正常吗难道五一也放假了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193985, encodeId=ad53219398535, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15626507481, createdName=ms5000002039979243, createdTime=Tue Mar 19 06:01:55 CST 2024, time=2024-03-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京)]

2023-11-14 ms7000001909487480 来自北京

偏重的研究方向：中药单体;心血管
经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。

32 18

展开18条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向：中药单体 经验分享：请问换编辑后with editor assessment要多久才能under review，已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=2024-05-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=36, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2153099, encodeId=a8222153099ee, content=请问各位，第一次投稿的editor assessment大概多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Wed Aug 16 22:06:19 CST 2023, time=2023-08-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2205178, encodeId=ab7122051e892, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理学 经验分享：最近看了几篇文章：文章1: 收稿2024.1.20；修改2024.5.5；接受2024.5.15 文章2: 收稿2023.11.9；修改2024.3.12；接受2024.4.22 文章3: 收稿2023.6.29；修改2023.12.28；接受2024.5.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Fri May 17 13:28:46 CST 2024, time=2024-05-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了，😭😭😭，正常吗难道五一也放假了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193985, encodeId=ad53219398535, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15626507481, createdName=ms5000002039979243, createdTime=Tue Mar 19 06:01:55 CST 2024, time=2024-03-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京)]

2024-03-19 ms5000002039979243 来自北京

审稿速度:24.0 | 投稿命中率:50.0
经验分享：慢

16 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向：中药单体 经验分享：请问换编辑后with editor assessment要多久才能under review，已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=2024-05-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=36, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2153099, encodeId=a8222153099ee, content=请问各位，第一次投稿的editor assessment大概多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Wed Aug 16 22:06:19 CST 2023, time=2023-08-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2205178, encodeId=ab7122051e892, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理学 经验分享：最近看了几篇文章：文章1: 收稿2024.1.20；修改2024.5.5；接受2024.5.15 文章2: 收稿2023.11.9；修改2024.3.12；接受2024.4.22 文章3: 收稿2023.6.29；修改2023.12.28；接受2024.5.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Fri May 17 13:28:46 CST 2024, time=2024-05-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了，😭😭😭，正常吗难道五一也放假了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193985, encodeId=ad53219398535, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15626507481, createdName=ms5000002039979243, createdTime=Tue Mar 19 06:01:55 CST 2024, time=2024-03-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京)]

2024-05-07 ms8000001555903844 来自北京

偏重的研究方向：药理学;心血管
经验分享：请问submit to journal到with editor这一步大家都等了多久啊

8 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务